NCT05486221

Brief Summary

The ARIES study is an observational study in which patients with a recent acute ischemic stroke of cryptogenic aetiology are consecutively enrolled in order to perform a extensive cardiologic work-up. The main objective is to study parameters that could predict arrythmias on prolonged monitoring and also echocardiographic parameters of left atrial disfunction that could predict the presence of a hidden atrial fibrilation and recurrent ischemic events in patients with cryptogenic stroke.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 17, 2020

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

August 2, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 3, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

August 3, 2022

Status Verified

May 1, 2022

Enrollment Period

2 years

First QC Date

August 2, 2022

Last Update Submit

August 2, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Analyze frequency of parafibrilatory status in cryptogenic stroke patients

    Analyze the frequency of parafibrilatory status defined as \> 3000 atrial ectopic beats per day or more or \>2 "micro-AF" episodes per day (fibrillatory burst \<30 seconds without a monomorphic P wave ) on 30 day ECG monitoring

    30 days

  • Analyze frequency of ecocardiographic parameters of atrial disfunction

    Dimensions and function of left atrium, telesystolic volume, left auricular ejection fraction, atrial longitudinal strain in 3 phases (reservoir, conduict, contractile)

    During hospitalization

  • Frequency of detection of atrial fibrilation

    Frequency of detection of atrial fibrilation lasting for more than 30 seconds on two 30 day ECG monitoring.

    60 days

  • Correlation of parafibrilatory state and echocardiographic parameters of atrial disfunction with the probability of detection of atrial fibrilation.

    Correlation of parafibrilatory state and echocardiographic parameters of atrial disfunction with the probability of detection of atrial fibrilation of more than 30 seconds of duration in 30-day ECG monitoring.

    30 days

  • Correlation of parafibrilatory state and echocardiographic parameters of atrial disfunction with the probability of stroke recurrence.

    Correlation of parafibrilatory state and echocardiographic parameters of atrial disfunction with the probability of stroke recurrence in patients without documented atrial fibrilation.

    At 3 months and 1 year.

Study Arms (1)

Cryptogenic stroke patients

Patients with an acute ischemic stroke of cryptogenic origin with a previous negative work-up that includes: blood analysis, brain CT / MRI, angio-TC / angio-MRI, brain vessel ultrasound, ECG, 24h ECG-holter, echocardiography).

Other: Extensive cardiologic work-up

Interventions

Specific 3D and 2D echocardiography measuring left ventricule and left atrial dimensions as well as longitudinal strain. 30 day prolonged ECG monitoring.

Cryptogenic stroke patients

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients older than 50 years old addmitted to the neurology ward in La Paz University Hospital with a recent diagnosis of cryptogenic ischemic stroke.

You may qualify if:

  • Patients addmitted to the Neurology service at La Paz University Hospital with a recent diagnosis of cryptogenic stroke considered non-lacunar and where no other reasonable diagnosis is suspected.
  • Signed informed consent.

You may not qualify if:

  • Presence of large vessel atheromatosis with \>50% estenosis, or \<50% but with two or more vascular risk factors (age \> 50 years old, hipertension, diabetes mellitus, dyslipidemia, smoker).
  • Patients with a un favorable clinical situation or dependance who will not benefit from the study or those that could not fullfill study visits and procedures.
  • Patients in which an embolic arrythmia has already been demonstrated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

La Paz University Hospital

Madrid, 28046, Spain

RECRUITING

MeSH Terms

Conditions

Ischemic StrokeAtrial Fibrillation

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesArrhythmias, CardiacHeart DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ricardo Rigual Bobillo, MD

    Hospital Universitario La Paz

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ricardo Rigual Bobillo, MD

CONTACT

Elena de Celis Ruiz, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2022

First Posted

August 3, 2022

Study Start

December 17, 2020

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

August 3, 2022

Record last verified: 2022-05

Locations